Evaluate DNA stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in DNA? | Glauxie AI

Q: What are the risks of investing in DNA?

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Jason Kelly. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as... Employees: 485.

Q: How much debt does DNA have?

Review DNA total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is DNA a good long-term investment?

Evaluate DNA as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in DNA?

🦉

Ginkgo Bioworks Holdings, Inc. (DNA)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOJason Kelly

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various...

Key Executives

Name	Title
Austin Che	Co-Founder & Head of Strategy
Bartholomew Canton	Co-Founder & CTO
Brian O'sullivan	Head of Commercial
Daniel Marshall	Senior Manager of Communications & Ownership
Jason Kelly	Co-Founder, Co-COO, CEO & Director
Jennifer Wipf	Co-Chief Operating Officer

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

DNA Profile Financials

Is DNA stock safe? How much debt does DNA have? Is DNA a good long-term investment?